Hepatic Resection of Metastatic Tumor from Serous Cystadenocarcinoma of the Ovary.
10.3346/jkms.2002.17.3.415
- Author:
Jong Hoon LEE
1
;
Kyung Sik KIM
;
Cheol Woon CHUNG
;
Young Nyun PARK
;
Byong Ro KIM
Author Information
1. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea. brkim@yumc.yonsei.ac.kr
- Publication Type:Case Reports
- Keywords:
Ovarian Neoplasms;
Cystadenocarcinoma;
Serous;
Neoplasm Metastasis;
Hepatectomy
- MeSH:
Cystadenocarcinoma, Serous/*secondary/*surgery;
Female;
Hepatectomy;
Humans;
Liver Neoplasms/*secondary/*surgery;
Middle Aged;
Ovarian Neoplasms/*pathology;
Tomography, X-Ray Computed
- From:Journal of Korean Medical Science
2002;17(3):415-418
- CountryRepublic of Korea
- Language:English
-
Abstract:
Metastatic carcinomas are the largest group of malignant tumors of the liver. But parenchymal liver metastasis from cystic ovarian adenocarcinoma is very rare. We report a case in which the resection of metastatic liver neoplasm from ovarian serous cystadenocarcinoma was done 7 yr after initial treatment. A 48-yr-old oriental housewife complained of easy fatigability and right lower quadrant discomfort. The hepatic mass was detected by ultrasonographic examination. Serum albumin, bilirubin, and aspartate aminotransferase/alanine aminotransferase were normal. Alkaline phosphatase level was slightly increased at 146 IU/L. A tumor marker study showed alpha-fetoprotein 0.97 IU/mL, carcinoembryonic antigen 0.965 ng/mL, cancer antigen 125 1,267 ng/mL and CA 19-9 106.1 ng/mL. The operation involved cholecystectomy and segmentectomy VI and VII of the liver. The patient recovered from the surgery without any complication. On the 10th postoperative day, the patient received a single-regimen chemotherapy with paclitaxel (Taxol, 155 mg/m2 BSA) and was discharged. She has been carefully followed-up without any evidence of recurrence after completion of the remaining 5 cycles of chemo-therapy, at intervals of three weeks.
